Synthesis and Self-Assembly of “Artificial Dinucleotide Duplexes”
J . Org. Chem., Vol. 63, No. 12, 1998 4089
130.8, 131.2, 131.3, 131.6, 141.2, 149.4, 160.5, 169.6, 170.0
ppm. LRMSFAB: 594 (M+), HRCIMS calcd for C33H27N2O9
595.1717, found 595.1729 (M + 1)+.
(m, 2H), 8.07 (d, J ) 16.5 Hz, 1H), 8.21 (s, 1H), 8.45 (s, 1H),
9.71 (s, 1H), 13.82 (bs, 1H) ppm. 13C NMR (CDCl3): δ -5.8,
-5.5, -5.4, -5.0, -4.9, -4.8, -4.7, -4.5, -4.4, 17.5, 17.7, 17.9,
18.1, 18.3, 18.7, 25.4, 25.6, 25.73, 25.9, 26.0, 26.3, 62.9, 63.3,
72.2, 72.7, 73.1, 83.4, 86.0, 86.14, 87.3, 87.6, 89.3, 91.6, 93.9,
101.2, 119.9, 120.0, 122.0, 124.6, 125.0, 127.4, 128.7, 129.2,
131.2, 131.2, 131.3, 131.5, 132.0, 132.9, 136.2, 140.6, 149.5,
150.2, 152.1, 154.8, 164.1 ppm. LRMSFAB: 1418 (M + 1)+,
HRMSFAB calcd for C73H116N7O10Si6 1418.7399 [M + 1]+ of
2, found 1418.7449. LRMSFAB: 2836 ((M + 1)+ of II),
HRMSFAB calcd for C146H231N14O20Si12 2836.4721 ((M + 1)+
of II), found 2836.4712.
For 8a . 1H NMR (CDCl3): δ 2.07 (s, 6H), 2.10 (s, 6H), 2.12
(s, 6H), 4.39 (m, 6H), 5.39 (t, 2H), 5.49 (t, 2H), 6.06 (d, 2H),
7.39 (dd, 2H), 7.68 (d, 2H), 7.96 (d, 2H), 7.99 (s, 2H), 8.38 (s,
1H), 9.45 (s, 1H), 9.76 (bs, 2H) ppm. 13C NMR (CDCl3): δ 20.4,
20.7, 62.7, 70.1, 73.5, 80.3, 85.7, 88.6, 91.9, 101.3, 120.8, 124.0,
124.9, 127.5, 129.3, 130.8, 131.2, 142.0, 149.5, 160.9, 169.1,
170.1, 170.3 ppm. LRMSFAB: 963 (M + 1)+, HRMSFAB calcd
for C48H42N4O18 962.2489, found 962.2494. Anal. Calcd for
C48H42N4O18: C, 59.88; H, 4.4; N, 5.82. Found: C, 59.73; H,
4.48; N, 5.64.
4,6-Dieth yn yld iben zofu r a n (11). This compound was
prepared by following General Procedure 1, using 10 (10.7 g,
25.5 mmol), TMS-acetylene (5.0 g, 51 mmol), 1.5 g (1.3 mmol)
of Pd(PPh3)4, 0.5 g (2.6 mmol) of CuI, and 100 mL of Et3N (50
°C, 15 h). Silica gel chromatography (hexanes eluent) gave
product (4,6-dibenzofuranyldiethynylene)bis(trimethylsilane)
as an intermediate in quantitative yield. LRMSCI(+): 361,
HRMSCI(+) calcd for C22H24OSi2 360.1366, found 360.1365.
The TMS group of this intermediate was removed by
reaction with KF (5.35 g, 92 mmol) while the solution was
heated in ethanol (300 mL) at reflux for 3 h. After the reaction
was allowed to cool to room temperature, the solvent was then
removed and the residue taken up in H2O (200 mL) and
extracted with CDCl3 (3 × 100 mL). The organic layer was
dried over Na2SO4 and evaporated to dryness. The residue
was purified by silica gel column chromatography using CHCl3
as the eluent. This gave product 11 (3.8 g) in 80% yield. 1H
NMR (CDCl3): δ 3.47 (s, 2H), 7.30 (t, J ) 7.8 Hz, 2H), 7.61 (d,
J ) 7.8 Hz, 2H), 7.92 (d, J ) 8.1 Hz, 2H) ppm. 13C NMR
(CDCl3): δ 82.9, 83.1, 107.5, 121.7, 123.2, 124.5, 131.7, 131.9
ppm.
5-Tr im e t h ylsilyle t h yn yl-4-h yd r oxyl-1-(2′,3′,5′-t r i-O-
a cetyl-â-D-r ibofu r a n osyl)p yr im id in -2-on e (14). This com-
pound was prepared by following General Procedure 1, using
6a (10 g, 20 mmol), TMS-acetylene (3.64 g, 37.1 mmol), 0.84 g
(1.2 mmol) of PdCl2(PPh3)2, 0.38 g (2 mmol) of CuI, 50 mL of
Et3N, and 50 mL of MeCN (50 °C, 15 h). Silica gel chroma-
tography using 4:3 ethyl acetate/hexanes as the eluent gave
the TMS-protected product 14 (0.91 g) in 91% yield. 1H NMR
(CDCl3): δ 0.11 (s, 9H), 2.00 (s, 3H), 2.02 (s, 3H), 2.11 (s, 3H),
4.28 (m, 3H), 5.24 (m, 2H), 6.01 (d, 1H), 7.70 (s, 1H), 9.83 (bs,
1H) ppm. 13C NMR (CDCl3): δ -0.5, 20.1, 20.2, 20.6, 62.7,
69.9, 73.0, 80.0, 87.1, 95.0, 99.6, 101.1, 141.9, 149.2, 160.7,
169.3, 169.4, 169.8 ppm. LRCI(+)MS: 467 ([M + 1]+), HRCI-
(+)MS calcd for C20H27N2O9Si 467.1486, found 467.1484.
5-Eth yn yl-4-h yd r oxy-1-(2′,3′,5′-tr i-O-acetyl-â-D-ribofura-
nosyl)pyrimidin-2-one (15). This compound was prepared by
following General Procedure 2, using 14 (0.91 g, mmol), TBAF
(20 mL, 1 M in THF, 20 mmol), and THF (200 mL) (rt, 4 h).
Silica gel chromatography (ethyl acetate eluent) gave product
15 (6.4 g) in 88% yield. 1H NMR (CDCl3): δ 2.05 (s, 3H), 2.12
(s, 3H), 2.20 (s, 3H), 3.23 (s, 1H), 4.40 (m, 3H), 5.36 (m, 2H),
6.09 (d, 1H), 7.31 (s, 1H), 7.87 (s, 1H) ppm. 13C NMR
(CDCl3): δ 20.2, 20.3, 20.7, 62.8, 69.9, 73.1, 74.5, 80.1, 82.3,
87.5, 100.0, 142.7, 149.2, 161.0, 169.4, 169.5, 170.0 ppm.
LRMSCI: 395 (M+), HRCIMS(+) calcd for C17H19N2O9 395.1091,
found 395.1085.
1-[4-Hyd r oxyl-5-eth yn yl-1-(2′,3′,5′-tr i-O-a cetyl-â-D-r ibo-
fu r an osyl)pyr im idin -2-on e]-8-[6-am in o-8-eth yn yl-9-(2′,3′,5′-
tr i-O-acetyl-â-D-r ibofu r an osyl)pu r in ]an th r acen e (1). This
compound was prepared by following General Procedure 1,
using 7a (3.2 g, 5.39 mmol), 8-bromoadenosine 9a (3.8 g, 8.05
mmol), 0.23 g (0.32 mmol) of PdCl2(PPh3)2, 0.10 g (0.54 mmol)
of CuI, 50 mL of Et3N, and 50 mL of MeCN (60 °C, 20 h). Silica
gel chromatography using first 3:1 ethyl acetate/hexane (to
remove unreacted 9a ) and then ethyl acetate as the eluent
gave product 1 (3.76 g) in 71% yield. 1H NMR (CDCl3): δ 1.74
(s, 3H), 1.87 (s, 3H), 1.94 (s, 3H), 2.16 (s, 3H), 2.20 (s, 3H),
2.40 (s, 3H), 3.96 (m, 2H), 4.11 (m, 2H), 4.58 (m, 2H), 4.87 (m,
1H), 5.26 (m, 1H), 5.47 (m, 1H), 6.02 (d, J ) 6.8 Hz, 1H), 6.50
(d, J ) 5.3 Hz, 1H), 6.60 (d, J ) 5.2 Hz, 1H), 6.70 (m, 1H),
7.10 (m, 2H), 7.20 (t, J ) 7.7 Hz, 1H), 7.52 (d, J ) 6.8 Hz,
1H), 7.85 (t, J ) 8.5 Hz, 2H), 8.30 (s, 1H), 8.35(s, 1H), 9.22 (s,
1H), 9.49 (bs, 1H), 14.68 (s, 1H) ppm. 13C NMR (CDCl3): δ
20.1, 20.2, 20.6, 21.2, 63.5, 63.7, 70.3, 70.3, 73.0, 74.6, 79.0,
80.2, 83.0, 84.5, 84.7, 88.4, 90.5, 94.3, 99.9, 119.2, 120.0, 120.3,
124.3, 124.9, 126.9, 128.3, 128.4, 130.6, 130.8, 131.1, 131.3,
131.5, 132.2, 136.1, 139.8, 139.8, 148.1, 149.4, 153.2, 155.3,
162.4, 168.4, 169.0, 169.8, 169.9, 170.5 ppm. LRMSFAB: 985
(M+), HRMSFAB calcd for C49H43N7O16 985.2766 (M+ of 1),
found 985.2757. LRMSFAB: 1970 (M+ of I), HRMSFAB calcd
for C98H86N14O32 1970.5533 (M+ of I), found 1970.5520. Anal.
Calcd for (C49H43N7O16)2‚(C6H6)2: C, 62.09; H, 4.64; N, 9.21.
Found: C, 62.07; H, 4.65; N, 9.17. Anal. Calcd for
(C49H43N7O16)2‚(C2H4Cl2)2: C, 56.5; H, 4.37; N, 9.05; Cl, 6.46.
Found: C, 56.51; H, 4.43; N, 8.94; Cl, 6.59.
4-H yd r oxy-5-[(8-e t h yn yl-1-a n t h r a ce n yl)e t h yn yl]-1-
(2′,3′,5′-tr i-O-ter t-bu tyld im eth ylsilyl-â-D-r ibofu r a n osyl)-
p yr im id in -2-on e (7b). This compound was prepared by
following General Procedure 1, using 1,8-diethynylanthracene
5 (1.0 g, 4.4 mmol), 5-iodo-2′,3′,5′-tri-O-tert-butyldimethylsi-
lyluridine 7b (1.5 g, 2.1 mmol), 0.090 g (0.12 mmol) of PdCl2-
(PPh3)2, 0.04 g (0.21 mmol) of CuI, and 50 mL of Et3N (rt, 5
h). Silica gel chromatography (1:4 ethyl acetate/hexanes
eluent) gave product 7b (1.2 g) in 70% yield. 1H NMR
(CDCl3): δ 0.04-0.12 (multiple-singlet (ms), 18H), 0.87-0.94
(ms, 27H), 3.72 (s, 1H), 3.74 (m, 1H), 3.97 (d, J ) 11.1 Hz,
1H), 4.11 (s, 2H), 4.25 (m, 1H), 6.09 (d, J ) 6.3 Hz, 1H), 7.41
(m, 2H), 7.73 (t, J ) 7.8 Hz, J ) 7.2 Hz, 2H), 7.99 (d, J ) 8.4
Hz, 2H), 8.19 (s, 1H), 8.40 (s, 1H), 8.43 (s, 1H), 9.55 (s, 1H)
ppm. 13C NMR (CDCl3): δ -5.4, -5.2, -4.7, -4.5, -4.4, 18.0,
18.1, 18.4, 25.8, 25.8, 26.1, 63.0, 72.7, 76.0, 81.5, 83.6, 85.9,
86.5, 88.4, 92.2, 101.0, 120.8, 121.1, 124.4, 124.9, 125.0, 127.4,
128.0, 128.2, 129.3, 130.4, 131.1, 131.4, 131.5, 131.8, 142.1,
149.3, 160.6 ppm. LRMSFAB: 810 (M+), HRMSFAB calcd for
5-[(6-Iod o-4-d ib e n zofu r a n yl)e t h yn yl-4-h yd r oxyl-1-
(2′,3′,5′-tr i-O-acetyl-â-D-r ibofu r an osyl)pyr im idin -2-on e (16)
a n d 4,6-Bis[4-h yd r oxyl-5-eth yn yl-1-(2′,3′,5′-tr i-O-a cetyl-
â-D-r ibofu r a n osyl)p yr im id in -2-on e]a n th r a cen e (13). This
compound was prepared by following General Procedure 1,
using 10 (5 g, 12 mmol), 15 (2.3 g, 6 mmol), 0.1 g (0.36 mmol)
of PdCl2(PPh3)2, 0.12 g (0.6 mmol) of CuI, 80 mL of Et3N, and
80 mL of MeCN (rt, 24 h). Silica gel chromatography using
first 2:1 ethyl acetate/hexane and then ethyl acetate as the
eluent gave 3.5 g of product 16 (87% yield) and 0.5 g of
compound 13 (9% yield) as a byproduct.
C
45H62N2O6Si3 810.3915, found 810.3906.
1-[4-H yd r oxy-5-et h yn yl-1-(2′,3′,5′-t r i-O-ter t-b u t yld im -
eth ylsilyl-â-D-r ibofu r an osyl)pyr im idin -2-on e]-8-[6-am in o-
8-et h yn yl-9-(2′,3′,5′-t r i-O-ter t-b u t yld im et h ylsilyl-â-D-r i-
bofu r a n osyl)p u r in e]a n th r a cen e (2). This compound was
prepared by following General Procedure 1, using 7b (0.8 g,
1.0 mmol), 9b (0.8 g, 1.1 mmol), 0.04 g (0.06 mmol) of PdCl2-
(PPh3)2, 0.02 g (0.1 mmol) of CuI, and 30 mL Et3N (60 °C, 4
h). Silica gel chromatography (3:1 ethyl acetate/hexanes
eluent) gave product 2 (0.91 g) in 65% yield. 1H NMR
(CDCl3): δ -0.65 to 1.05 (ms, 90 H), 3.74-4.22 (m, 9H), 5.10
(m, 1H), 6.17 (d, J ) 6.0 Hz, 1H), 6.40 (d, J ) 7.5 Hz, 1H),
6.70 (bs, 2H), 7.48 (q, J ) 8.1 Hz, 2H), 7.67 (d, J ) 6.9 Hz,
1H), 7.89 (d, J ) 6.9 Hz), 1H), 7.99 (d, J ) 8.4 Hz, 1H), 8.05
For 16. LRMSFAB: 687 (M + 1)+, HRCIMS(+) calcd for
29H23N2O10I 686.0397, found 686.0391. This compound was
C
used without further purification in the ensuing step.
For 13. 1H NMR (CDCl3): δ 2.11 (s, 6H), 2.13 (s, 6H), 2.25
(s, 6H), 4.43 (m, 6H), 5.52 (m, 4H), 6.12 (d, 2H), 7.34 (t, 2H),